Concepedia

Publication | Open Access

YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway

DOIFull Paper Access

35

Citations

27

References

2019

Year

Hui Tong, Kai Zhao, Jingyu Zhang, Jinxin Zhu, Jianqi Xiao
Drug Design Development and Therapy

Abstract

YB-1 facilitates the resistance of glioma cells to TMZ by direct activation of MDM2/p53 signaling and represents a promising molecular target for glioma treatment.

References

YearCitations

Page 1